Canaccord Genuity Reiterates Buy on Doximity, Maintains $40 Price Target
Portfolio Pulse from richadhand@benzinga.com
Canaccord Genuity analyst Richard Close has reiterated a Buy rating on Doximity (NYSE:DOCS) and maintained a $40 price target.

June 07, 2023 | 2:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Canaccord Genuity analyst Richard Close reiterated a Buy rating on Doximity (NYSE:DOCS) and maintained a $40 price target.
The Buy rating and maintained $40 price target by Canaccord Genuity analyst Richard Close indicates a positive outlook for Doximity's stock. This news is highly relevant and important for investors in DOCS, as it suggests potential upside in the short term. The confidence in this analysis is high due to the analyst's expertise and the direct mention of DOCS in the article.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100